Axsome Therapeutics, Inc.
Axsome Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS) disorders.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Axsome Therapeutics' stock with a target price of $174.3, indicating strong potential growth.
Financial Health
Axsome Therapeutics is generating strong profits and cash flow, indicating solid financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AXSM
Early Alzheimer's Detection: Could Blood Tests Replace Scans?
The FDA's approval of Roche and Eli Lilly's blood test marks a pivotal shift toward early and accessible Alzheimer's diagnosis in primary care. This breakthrough is expected to accelerate growth for companies in the diagnostics sector and expand the market for new Alzheimer's treatments.
Published: October 14, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Commercialisation Phase
Approved products offer near-term revenue potential, but growth depends on uptake and reimbursement — performance can vary and is not guaranteed.
Pipeline Catalysts
Clinical programmes for migraine and other CNS conditions could drive value if trials succeed, though clinical outcomes are inherently uncertain.
Market Positioning
At roughly $6.56bn market cap, Axsome’s trajectory depends on market access, partnerships and execution; biotech stocks can be volatile and subject to binary events.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
